BBIO vs POOL
BridgeBio Pharma Inc (BBIO) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
BBIO currently screens at market cap $13.24B. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the BBIO and POOL stock pages for the full models.
Not investment advice.